KR101066676B1 - 경구용 피부 미용 개선용 조성물 - Google Patents
경구용 피부 미용 개선용 조성물 Download PDFInfo
- Publication number
- KR101066676B1 KR101066676B1 KR1020050042358A KR20050042358A KR101066676B1 KR 101066676 B1 KR101066676 B1 KR 101066676B1 KR 1020050042358 A KR1020050042358 A KR 1020050042358A KR 20050042358 A KR20050042358 A KR 20050042358A KR 101066676 B1 KR101066676 B1 KR 101066676B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- skin
- red ginseng
- soybean extract
- powder
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 230000003796 beauty Effects 0.000 title abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 93
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 68
- 235000020712 soy bean extract Nutrition 0.000 claims abstract description 62
- 239000012141 concentrate Substances 0.000 claims abstract description 40
- 230000037303 wrinkles Effects 0.000 claims abstract description 20
- 235000013305 food Nutrition 0.000 claims abstract description 11
- 230000006872 improvement Effects 0.000 claims abstract description 8
- 229920000858 Cyclodextrin Polymers 0.000 claims description 30
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 13
- 239000002537 cosmetic Substances 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 10
- 239000003826 tablet Substances 0.000 claims description 8
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 7
- 229960004853 betadex Drugs 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 6
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 6
- 235000008696 isoflavones Nutrition 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 4
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 14
- 235000010469 Glycine max Nutrition 0.000 abstract description 13
- 239000000284 extract Substances 0.000 abstract description 11
- 230000009759 skin aging Effects 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 6
- 230000037380 skin damage Effects 0.000 abstract description 3
- 230000037394 skin elasticity Effects 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 230000015556 catabolic process Effects 0.000 abstract description 2
- 238000006731 degradation reaction Methods 0.000 abstract description 2
- 102000034240 fibrous proteins Human genes 0.000 abstract description 2
- 108091005899 fibrous proteins Proteins 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 32
- 108010035532 Collagen Proteins 0.000 description 13
- 102000008186 Collagen Human genes 0.000 description 13
- 229920001436 collagen Polymers 0.000 description 12
- 210000002950 fibroblast Anatomy 0.000 description 12
- 108010050808 Procollagen Proteins 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 10
- 244000068988 Glycine max Species 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 239000001116 FEMA 4028 Substances 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 6
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 5
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 230000037319 collagen production Effects 0.000 description 5
- 239000011812 mixed powder Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 102000029816 Collagenase Human genes 0.000 description 4
- 108060005980 Collagenase Proteins 0.000 description 4
- 206010051246 Photodermatosis Diseases 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 235000001727 glucose Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000008845 photoaging Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229960002424 collagenase Drugs 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 229940097362 cyclodextrins Drugs 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229930002330 retinoic acid Natural products 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 238000011891 EIA kit Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 235000010724 Wisteria floribunda Nutrition 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- -1 cyclic oligosaccharides Chemical class 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- 229930012930 isoflavone derivative Natural products 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040867 Skin hypertrophy Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- 230000036252 glycation Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000037333 procollagen synthesis Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Description
처리군 | 콜라겐 생성능 |
비타민 C (10 ppm) | 27.8% 증가 |
TGF-b (10 ng/ml) | 26.2% 증가 |
홍삼· 대두 추출 혼합물(1ppm) | 11.5% 증가 |
홍삼· 대두 추출 혼합물(10ppm) | 22.7% 증가 |
처리군 | MMP-1 합성능 |
레티노익산 (1mM) | 51.6 % 감소 |
TGF-b(10 ng/ml) | 67.3 % 감소 |
홍삼· 대두 추출 혼합물(1ppm) | 29.7 % 감소 |
홍삼· 대두 추출 혼합물(10ppm) | 33.1 % 감소 |
처리군 | UV조사 | 투여량 | 동물수 | 투여경로 |
대조군 | X | 식염수 10 ml/kg | 10 | 경구 |
UV/con | O | 식염수 10 ml/kg | 10 | 경구 |
A | O | 대두추출분말 8 mg/10 ml/kg 홍삼농축액분말 5 mg/10 ml/kg |
10 | 경구 |
B | O | 대두추출분말 80 mg/10 ml/kg 홍삼농축액분말 50 mg/10 ml/kg |
10 | 경구 |
C | O | 대두추출분말 8 mg/10 ml/kg | 10 | 경구 |
D | O | 홍삼농축액분말 5 mg/10 ml/kg | 10 | 경구 |
처리군 | 표피층 두께 |
정상군 | 9.45 ± 0.69 mm |
UV 대조군 | 31.6 ± 3.68 mm (100%) |
UV/ A(홍삼 대두 추출 혼합물 투여군(x1)) | 23.92 ± 4.25 mm (76%) |
UV/ B(홍삼 대두 추출 혼합물 투여군(x10)) | 24.7 ± 4.85 mm (75%) |
UV/ C(대두 추출 분말) | 30.87 ± 3.59 mm (98%) |
UV/ D(홍삼 농축액 분말) | 31.02 ± 3.05 mm (98%) |
Claims (11)
- 활성 성분으로서 대두 추출 분말 및 홍삼 농축액 분말을 함유하는 경구용 피부 미용 개선용 조성물.
- 제 1항에 있어서, 상기 대두 추출 분말은 조성물 총 중량에 대하여 10∼80 중량%를 함유하는 것임을 특징으로 하는 경구용 피부 미용 개선용 조성물.
- 제 2항에 있어서, 상기 대두 추출 분말은 이소플라본을 10∼70% 함유하는 것임을 특징으로 하는 경구용 피부 미용 개선용 조성물.
- 제 1항에 있어서, 상기 홍삼 농축액 분말은 조성물 총 중량에 대하여 10∼80 중량%를 함유하는 것임을 특징으로 하는 경구용 피부 미용 개선용 조성물.
- 제 4항에 있어서, 상기 홍삼 농축액 분말은 조사포닌 함량이 105mg/g 이상을 함유하는 것임을 특징으로 하는 경구용 피부 미용 개선용 조성물.
- 제 1항에 있어서, 상기 대두 추출 분말은 사이클로덱스트린(cyclodextrin)으로 포접된 것임을 특징으로 하는 경구용 피부 미용 개선용 조성물.
- 제 6항에 있어서, 상기 대두 추출 분말은 사이클로덱스트린(cyclodextrin)에 대하여 대두 추출물의 건조 중량비가 1:0.1 내지 1:50이 되도록 사이클로덱스트린(cyclodextrin)으로 포접하는 것임을 특징으로 하는 경구용 피부 미용 개선용 조성물.
- 제 6항에 있어서, 상기 사이클로덱스트린(cyclodextrin)은 알파-, 베타- 또는 감마-사이클로덱스트린 그 자체 또는 그의 유도체임을 특징으로 하는 경구용 피부 미용 개선용 조성물.
- 제 1항에 있어서, 상기 조성물은 피부 미용 식품 조성물임을 특징으로 하는 경구용 피부 미용 개선용 조성물.
- 제 9항에 있어서, 상기 조성물은 환제, 정제, 캡슐제, 연질 캡슐제, 과립제 및 드링크제로 이루어진 군에서 선택된 제형으로 제형화됨을 특징으로 하는 경구용 피부 미용 개선용 조성물.
- 제 1항 내지 제 10항 중 어느 한 항에 있어서, 상기 조성물은 피부 주름 개선용임을 특징으로 하는 경구용 피부 미용 개선용 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050042358A KR101066676B1 (ko) | 2005-05-20 | 2005-05-20 | 경구용 피부 미용 개선용 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050042358A KR101066676B1 (ko) | 2005-05-20 | 2005-05-20 | 경구용 피부 미용 개선용 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060119384A KR20060119384A (ko) | 2006-11-24 |
KR101066676B1 true KR101066676B1 (ko) | 2011-09-21 |
Family
ID=37706254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050042358A KR101066676B1 (ko) | 2005-05-20 | 2005-05-20 | 경구용 피부 미용 개선용 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101066676B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200098153A (ko) | 2019-02-12 | 2020-08-20 | 주식회사 진트론바이오텍 | 황칠나무 및 자색고구마 추출발효물을 유효성분으로 함유하는 피부 주름 또는 피부 광노화의 예방 또는 개선용 조성물 |
KR20200103347A (ko) | 2019-02-25 | 2020-09-02 | 주식회사 샤이닝 | 스테비아 및 화산석 송이 추출발효물을 유효성분으로 함유하는 피부 주름 또는 피부 광노화의 예방 또는 개선용 조성물 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100929920B1 (ko) | 2007-09-05 | 2009-12-04 | 주식회사 마크로케어 | 사이클로덱스트린 및 이의 유도체에 소수성 생리활성성분이 포접된 포접체의 제조방법 및 이로써 제조된포접체의 용도 |
KR100970455B1 (ko) * | 2008-02-11 | 2010-07-16 | 주식회사 비티씨 | 초고압을 이용한 인삼 추출물의 제조방법 |
US20220193163A1 (en) | 2019-04-24 | 2022-06-23 | G&P Bioscience Co., Ltd. | Composition comprising actinidia polygama extract for alleviating skin damage or moisturizing skin |
KR20200124628A (ko) | 2019-04-24 | 2020-11-03 | 주식회사 지앤피바이오사이언스 | 개다래 추출물을 포함하는 피부 손상 개선용 또는 피부 보습용 조성물 |
KR20200124590A (ko) | 2019-04-24 | 2020-11-03 | 주식회사 지앤피바이오사이언스 | 개다래 추출물을 포함하는 피부 손상 개선용 또는 피부 보습용 조성물 |
KR102286969B1 (ko) | 2019-06-21 | 2021-08-06 | (주) 바이텍 | 정제어유 유래 오메가-7 및 홍삼을 포함하는 피부 상태 개선용 조성물 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11269066A (ja) | 1998-03-20 | 1999-10-05 | Kao Corp | 経口用美白剤及び美白用食品 |
KR20000042616A (ko) * | 1998-12-26 | 2000-07-15 | 강석창 | 홍삼을 주재로 한 화장료 |
-
2005
- 2005-05-20 KR KR1020050042358A patent/KR101066676B1/ko active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11269066A (ja) | 1998-03-20 | 1999-10-05 | Kao Corp | 経口用美白剤及び美白用食品 |
KR20000042616A (ko) * | 1998-12-26 | 2000-07-15 | 강석창 | 홍삼을 주재로 한 화장료 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200098153A (ko) | 2019-02-12 | 2020-08-20 | 주식회사 진트론바이오텍 | 황칠나무 및 자색고구마 추출발효물을 유효성분으로 함유하는 피부 주름 또는 피부 광노화의 예방 또는 개선용 조성물 |
KR20200103347A (ko) | 2019-02-25 | 2020-09-02 | 주식회사 샤이닝 | 스테비아 및 화산석 송이 추출발효물을 유효성분으로 함유하는 피부 주름 또는 피부 광노화의 예방 또는 개선용 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20060119384A (ko) | 2006-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI381834B (zh) | Abnormal protein removal composition | |
KR101841256B1 (ko) | 피부주름 개선 및 탄력 증진용 조성물 | |
KR101066676B1 (ko) | 경구용 피부 미용 개선용 조성물 | |
KR101776071B1 (ko) | 붉은 작두콩 추출물을 함유하는 항노화 및 미백용 조성물 | |
US20080206175A1 (en) | Composition for Skin Whitening and Wrinkle Improvement Comprising Vaccinium Uliginosum Extract and Method for Preparation Thereof | |
US20100323044A1 (en) | Abnormal protein removing method | |
KR101902911B1 (ko) | 산수국 추출물을 함유하는 자외선에 의한 인간 피부세포 손상 개선용 조성물 | |
KR101787074B1 (ko) | 천연물 복합 추출물을 포함하는 피부 미백 및 피부 주름 개선용 화장료 조성물 | |
CN102973937A (zh) | 具有皮肤美容功效的组合物及包含该组合物的口服化妆品 | |
KR101721022B1 (ko) | 아디프산을 유효성분으로 함유하는 피부주름개선 및 피부탄력증진용 조성물 | |
KR20120131065A (ko) | 아위느타리버섯 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화 예방 또는 개선용 조성물 | |
KR102189415B1 (ko) | 대황 추출물을 유효성분으로 포함하는 자외선에 의한 피부 손상 예방 또는 개선을 위한 조성물 | |
JP2023118853A (ja) | 抗老化用組成物、抗老化用皮膚化粧料および抗老化用飲食品 | |
KR102303400B1 (ko) | 제주 용암해수, 제주 보리누룩 및 천연식물을 이용한 발효물 제조방법 및 이를 포함하는 화장품 조성물 및 그 제조방법 | |
KR102176883B1 (ko) | 복사나무 수지를 함유하는 피부 재생, 주름 개선, 또는 상처 치유용 조성물 | |
KR20160054673A (ko) | 마치현 추출물을 포함하는 히알루론산 생성 촉진용 조성물과 이의 이용 | |
KR102577528B1 (ko) | 피부 개선용 조성물 | |
KR101230935B1 (ko) | 경구용 피부 미용 개선용 조성물 | |
KR101010715B1 (ko) | 피부 질환의 예방 및 치료용 생약조성물 | |
CN106389141A (zh) | 用于改善皮肤的组合物 | |
KR101459741B1 (ko) | 가루녹차를 함유하는 경구용 피부미용 개선용 조성물 | |
KR20160054672A (ko) | 대맥자 추출물을 포함하는 히알루론산 생성 촉진용 조성물과 이의 이용 | |
KR102469725B1 (ko) | 들쭉나무 열매 분말을 함유하는 피부노화 개선용 조성물 | |
KR100563673B1 (ko) | 피부 주름 개선 및 피부 주름 생성 억제용 건강기능식품 | |
KR20230157782A (ko) | 산초나무 오일을 유효성분으로 포함하는 피부 손상 예방 또는 개선용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140829 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150901 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20160624 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170628 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180702 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190701 Year of fee payment: 9 |